Insider Transactions in Q2 2022 at Concert Pharmaceuticals, Inc. (CNCE)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 09
2022
|
Richard Aldrich Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,400
+4.37%
|
-
|
|
Jun 09
2022
|
Thomas G Auchincloss Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,400
+32.52%
|
-
|
|
Jun 09
2022
|
Jesper Hoeiland Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,400
+43.24%
|
-
|
|
Jun 09
2022
|
Peter Barton Hutt Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,400
+35.74%
|
-
|
|
Jun 09
2022
|
Wilfred E Jaeger Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,400
+43.24%
|
-
|
|
Jun 09
2022
|
Christi Van Heek Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,400
+28.06%
|
-
|
|
Jun 06
2022
|
Richard Aldrich Director |
BUY
Open market or private purchase
|
Indirect |
210,526
+50.0%
|
$842,104
$4.75 P/Share
|
|
Jun 06
2022
|
Thomas G Auchincloss Director |
BUY
Open market or private purchase
|
Direct |
6,000
+25.4%
|
$24,000
$4.75 P/Share
|
|
Jun 06
2022
|
Christi Van Heek Director |
BUY
Open market or private purchase
|
Direct |
10,526
+29.1%
|
$42,104
$4.75 P/Share
|